Z_3_08 — Genetics of Taste and Smell

Taste and smell perception are profoundly shaped by genetics, with variation in chemosensory receptor genes producing dramatically different sensory worlds between individuals. The olfactory receptor (OR) gene family — d

Z_3_04 — Comparative Genomics and Cross-Species Analysis

Comparative genomics — the systematic comparison of genome sequences across species — has become the primary tool for understanding genome evolution, identifying functionally important sequences, and reconstructing the T

Z_3_02 — Epigenetic Inheritance & Transgenerational Effects

Epigenetic inheritance refers to the transmission of phenotypic information across generations through mechanisms other than changes in DNA sequence. The three primary molecular mechanisms — DNA methylation, histone modi

Z_3_09 — Conservation Genetics and Endangered Species

Conservation genetics applies population genetics, genomics, and molecular biology to the preservation of biological diversity. At its core is the recognition that genetic diversity — the raw material for adaptation to c

Z_3_10 — Genetics of Athletic Performance

Athletic performance is a highly polygenic trait with substantial heritability — twin studies estimate heritability of VO2max (maximal oxygen uptake) at ~50% (Bouchard et al., 1999, HERITAGE Family Study), muscle fiber c

Z_3_11 — Genetic Mosaicism and Chimerism

A fundamental assumption of genetics — that every cell in an individual's body carries the same genome — is wrong. Genetic mosaicism (the presence of two or more genetically distinct cell populations within an individual

Z_2_15 — Future of Genomics and Personalized Medicine

Genomics is undergoing a transition from research tool to clinical infrastructure. The cost of whole-genome sequencing (WGS) has plummeted from $2.7 billion (Human Genome Project, 1990–2003) to ~$200 per genome (Illumina

Z_2_13 — Pharmacogenomics and Personalized Medicine

Pharmacogenomics — the study of how genetic variation influences drug response — is among the most clinically actionable applications of human genetics. Adverse drug reactions (ADRs) are the 4th–6th leading cause of deat

Z_2_10 — Genetics of Aging and Progeria

Aging — the progressive decline in physiological function leading to increased vulnerability to disease and death — has a substantial genetic component: twin studies estimate heritability of human lifespan at ~25–30% (He

Z_2_03 — Pharmacogenomics & Ethnobotanical Genetics

Pharmacogenomics — the study of how genetic variation affects drug response — has revealed that enzymes governing drug metabolism, particularly the cytochrome P450 (CYP) superfamily, show extraordinary population-specifi

Z_2_08 — Prion Genetics and Misfolded Proteins

Prions are infectious agents composed entirely of misfolded protein — the only known pathogen that contains no nucleic acid (no DNA, no RNA). The protein-only hypothesis (Stanley Prusiner, 1982 — Nobel Prize 1997) states

Z_2_12 — Genetics of Pain Perception

Pain perception — the subjective experience triggered by actual or potential tissue damage — varies enormously across individuals, with genetic factors accounting for 25–50% of the variance in pain sensitivity (twin stud

Z_2_09 — Mitochondrial Genetics and Diseases

Human mitochondrial DNA (mtDNA) is a 16,569-bp circular genome encoding 37 genes: 13 proteins (all subunits of the oxidative phosphorylation/OXPHOS complexes I, III, IV, and V), 22 transfer RNAs, and 2 ribosomal RNAs. Un

Z_2_04 — Genetic Disorders and Inborn Errors of Metabolism

Genetic disorders — diseases caused by mutations in single genes (monogenic) or chromosomal abnormalities — affect ~3–5% of live births and collectively represent thousands of distinct conditions catalogued in the Online

Z_2_06 — Nutrigenomics and Diet-Gene Interactions

Nutrigenomics — the study of how genetic variation influences nutritional requirements, dietary responses, and disease susceptibility — and its complement nutrigenetics (how diet influences gene expression) represent a r

Z_2_14 — Genetics of Longevity and Blue Zones

The genetics of human longevity — why some individuals live past 100 while most do not — is a field where heritability is modest, effect sizes are small, and environmental factors dominate, yet several genetic pathways h

Z_2_02 — Telomere Biology & Genetics of Aging

Telomeres — repetitive DNA sequences (TTAGGG)ₙ capping the ends of linear chromosomes — serve as protective buffers against chromosome degradation, end-to-end fusion, and the progressive DNA loss inherent in the end-repl

Z_2_00 — Medical Genetics Health: Subfolder Summary

Z_2_07 — Genetics of Disease Resistance

Infectious disease has been the most powerful selective force shaping the human genome, leaving signatures across thousands of loci. The best-understood example is sickle cell disease (HbS, Glu6Val in HBB): heterozygous

Z_2_05 — Gene Therapy: History and Progress

Gene therapy — the introduction, alteration, or replacement of genetic material within a patient's cells to treat or cure disease — has evolved from a speculative concept to an approved clinical reality over five decades